Jefferies bullish on Disc Medicine, calls bitopertin a blockbuster in the making
On Wednesday, Disc Medicine (NASDAQ:IRON) stock received a Buy rating from a Jefferies analyst, with a price target set at ...
Monday, January 6, 2025
Tag: Blockbuster
Blockbuster BeiGene Cancer Drug Adds Another FDA Approval
A BeiGene drug already used to treat several types of blood cancer now has an additional FDA approval as a ...
FDA Approves Sandoz Biosimilars for Two Blockbuster Amgen Bone Drugs
A blockbuster Amgen antibody that treats bone conditions is set to face its first biosimilar competition. The FDA on Tuesday ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.